Furthermore, CSF neurofilament light chain (Nfl) and glial fibrillary acidic protein (GFAP) values were not significantly different in AD patients with or without epilepsy, suggesting that epilepsy is specifically associated with AD pathology rather than other neurodegenerative alterations affecting these markers [68]. Here, GFAP is linked to Alzheimer disease.